Vivo Capital, LLC Delcath Systems, Inc. Put Options Transaction History
Vivo Capital, LLC
- $748 Million
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding DCTH
# of Institutions
40Shares Held
7.37MCall Options Held
143KPut Options Held
60.8K-
Aigh Capital Management LLC Baltimore, MD2.36MShares$18.7 Million4.54% of portfolio
-
Bvf Inc San Francisco, CA1.2MShares$9.51 Million0.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA684KShares$5.41 Million0.0% of portfolio
-
Cibc World Market Inc. Toronto, A6260KShares$2.06 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA223KShares$1.76 Million0.0% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $68M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...